Author

Jia Lu

Institution: Innovent Biologics (China)

Observed institution: Innovent Biologics (China)

ORCID: 0009-0000-8012-2988

Observed ORCID: 0009-0000-8012-2988

OpenAlex ID: A5126737899

B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities

2026 · Jian Guan, Tiongsun Chia, et al. · Nature Communications · 3

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity

2026 · Jia Liu, Jingbo Ma, et al. · Cancer Research

Works count: 2

Citation count: 3

H-index: 1

I10-index: